<DOC>
	<DOCNO>NCT00436592</DOCNO>
	<brief_summary>The purpose study assess safety feasibility NeuroFloâ„¢ catheter treat patient ischemic stroke whose last time symptom-free 8-24 hour prior treatment . The NeuroFlo device intend increase blood flow brain potentially reduce damage cause stroke .</brief_summary>
	<brief_title>Safety Efficacy NeuroFlo 8-24 Hour Stroke Patients</brief_title>
	<detailed_description>The study prospective , single arm treatment feasibility trial determine baseline safety feasibility NeuroFlo device acute ischemic stroke patient whose last known time symptom-free 8-24 hour . A maximum 25 patient 5 US site 25 patient 10 Canadian &amp; European sit may enrol initial study phase . An independent data safety monitor board assess safety treatment routine basis .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Ischemic stroke NIHSS 420 Time symptom onset 8 24 hour Hemorrhagic stroke Certain type heart disease Kidney disease Other condition doctor ass</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>acute</keyword>
	<keyword>ischemic</keyword>
	<keyword>stroke</keyword>
	<keyword>device</keyword>
	<keyword>treatment</keyword>
</DOC>